Needham & Company
View Older Stories
-
Medtronic, Inc. (MDT) PT Raised to $152 at Needham & Company, Following Earnings
-
Medtronic, Inc. (MDT) PT Raised to $146 at Needham & Company, Following Earnings
-
Needham & Company Downgrades Medtronic, Inc. (MDT) to Buy
-
Medtronic, Inc. (MDT) PT Raised to $134 at Needham & Company
-
Medtronic, Inc. (MDT) PT Raised to 'Street High' $133 at Needham & Company
-
Medtronic, Inc. (MDT) PT Raised to $120 at Needham & Company Following Mazor Deal
-
UPDATE: Needham & Company Upgrades Medtronic, Inc. (MDT) to Strong Buy
-
Medtronic, Inc. (MDT) PT Raised to $103 at Needham & Company
-
Medtronic, Inc. (MDT) PT Raised to $97 at Needham & Company
-
Medtronic, Inc. (MDT) PT Bumped to $95 at Needham & Company
-
Medtronic, Inc. (MDT) PT Lowered to $94 at Needham & Company; 'Lowering Estimates for Hurricane Maria Manufacturing Impact'
-
Pre-Open Movers 08/22: (DSW (RT) (JASO) Higher; (TEAR) (CMCM) (NDSN) Lower (more...)
-
Abbott profit forecast gets a lift from St. Jude integration
-
Mazor Robotics (MZOR): Takeout Unlikely Here - Needham
-
Medtronic (MDT): Increased Comfort in Growth Targets - Needham
-
Medtronic, Inc. (MDT) PT Raised to $91 at Needham & Company
-
Needham & Company Maintains Buy on Medtronic (MDT) Amid Possible Unit Sale
-
Needham & Company Cuts Price Target on Medtronic (MDT) to $84 Following 2Q
-
ResMed (RMD), St. Jude (STJ), Cepheid (CPHD) Among Med Tech Companies with Most EU Exposure - Needham & Company
-
Needham & Company Raises Price Target on Medtronic (MDT) Following Biennial Investor Day
-
Needham & Company Cuts Price Target on Medtronic (MDT) as 3Q Revenue Misses Mark
-
Medtronic (MDT) PT Bumped to $91 at Needham & Company Post Q4
-
Medtronic (MDT) PT Raised to $90 at Needham & Company Post Q4
-
Pre-Open Stock Movers 9/23: (RWLK) (TKMR) (SLXP) Higher; (ASNA) (KMX) (AVNR) Lower (more...)
-
Needham & Company Comments on Sector Implications Amid Medtronic (MDT)/Covidien (COV) Megadeal
-
CONMED (CNMD) Worth up to $59/Share in Takeover - Needham & Company
-
Notable Analyst Rating Changes 04/15: (CHS) (C) (YHOO) Upgraded; (WMT) (PETM) (MDT) Downgraded
-
Notable Analyst Rating Changes 10/23: (MDT) (DD) (GNTX) Upgraded; (GS) (EXC) (COH) Downgraded
-
Notable Analyst Rating Changes 02/23: (AMAT) (AKS) (YOKU) (HOC) Upgraded; (NFLX) (FRX) (MDT) (MRO) Downgraded
-
Needham & Co Reiterates a 'Buy' on Medtronic (MDT); Represents Core Holding in Medical Devices
-
Needham & Co's Top MedTech Picks: MDT, SYK, ISRG, NUVA